Condition: Subjective Cognitive Decline (SCD) · Sponsor: Hebrew University of Jerusalem
The goal of this feasibility study is to test the feasibility of a group intervention program based on health management principles for older adults with Subjective Cognitive Decline (SCD). SCD is a condition where individuals feel that their memory is worsening, although standard tests do not detect it. This perceived memory decline can lead to negative feelings and self-perception, causing people to withdraw from meaningful activities. This study aims to answer three main questions: 1. Is the intervention feasible in terms of fidelity, adherence, and participant satisfaction? 2. Are the assessments used sensitive enough to identify the unique challenges faced by the SCD population and detect changes after the intervention? 3. What are the preliminary effects of the intervention on participants' perceptions of how SCD affects their daily life, mental health, and quality of life? Participants will: 1. Take part in 14 weekly group sessions focused on managing the challenges of living with SCD and improving participation in daily activities. 2. Complete assessments before and after the intervention to measure their satisfaction with the program, and track changes in their perceptions of daily life, mental health, and quality of life.
This description comes directly from the study's public registry record.
Adina Maeir, PhD · 972-546-205081 · adina.maeir@mail.huji.ac.il
Always discuss trial participation with your own doctor first.
| Hebrew University of Jerusalem | Jerusalem, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06632145